Eli Lilly and (LLY) has had the highest return since 2011 by a US stock in the Pharmaceuticals Industry, returning 3,017%.
| ASSET | % RETURN |
|---|---|
Eli Lilly and (LLY) | 3,017% |
Corcept Therapeutics (CORT) | 1,231.44% |
Cronos (CRON) | 1,122.89% |
Novo Nordisk A-S (NVO) | 906.57% |
Axsome Therapeutics (AXSM) | 845.89% |
Intracellular Th (ITCI) | 717.8% |
Prestige Brand (PBH) | 532.75% |
Jazz Pharmaceuticals (JAZZ) | 512.78% |
Zoetis (ZTS) | 474.87% |
Supernus Pharmaceuticals (SUPN) | 470% |
Amphastar P (AMPH) | 406.14% |
AstraZeneca PLC ADR (AZN) | 394.55% |
Merck (MRK) | 355.71% |
Tarsus Pharmaceuticals (TARS) | 246.91% |
Novartis AG ADR (NVS) | 244.47% |
Johnson & Johnson (JNJ) | 244.03% |
Bristol-Myers Squibb (BMY) | 240.57% |
Verona Pharma PLC ADR (VRNA) | 231.93% |
Catalent (CTLT) | 217.4% |
Dr Reddy’s Laboratories Ltd ADR (RDY) | 199.63% |
Pfizer (PFE) | 175.64% |
Pacira BioSciences (PCRX) | 166.14% |
Sanofi ADR (SNY) | 151.08% |
Collegium Pharmaceutical (COLL) | 138.5% |
Eton Pharmaceuticals (ETON) | 90.3% |
